세계의 족저근막염 치료 시장 보고서(2025년)

Plantar fasciitis treatment involves medical care or preventive measures aimed at assessing the occurrence and frequency of a degenerative condition affecting the thick band of tissue at the base of the foot. An integral aspect of treating plantar fasciitis is physical therapy.

The primary categories of plantar fasciitis treatment include medication therapy, orthotics, shockwave therapy, surgery, and other interventions. Medication therapy involves treating the condition using prescription or non-prescription medicines, over-the-counter medications, and herbal remedies. Diagnosis typically relies on medical history, physical examination, X-rays, radiography, and other diagnostic methods and is administered by hospitals, clinics, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The plantar fasciitis treatment market research report is one of a series of new reports from The Business Research Company that provides plantar fasciitis treatment market statistics, including plantar fasciitis treatment industry global market size, regional shares, competitors with a plantar fasciitis treatment market share, detailed plantar fasciitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the plantar fasciitis treatment industry. This plantar fasciitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plantar fasciitis treatment market size has grown exponentially in recent years. It will grow from $1.68 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to alternative therapies, patient education and awareness, pain management solutions, rise in sports injuries, physical therapy techniques.

The plantar fasciitis treatment market size is expected to see exponential growth in the next few years. It will grow to $4.69 billion in 2029 at a compound annual growth rate (CAGR) of 22.6%. The growth in the forecast period can be attributed to regulatory changes and approvals, patient-centric approaches, research and clinical trials, focus on personalized medicine, growing aging population. Major trends in the forecast period include focused rehabilitation techniques, innovations in orthopedic devices, biomechanical studies, alternative therapies advancements, patient education and self-care.

The forecast of 22.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could inflate prices of extracorporeal shockwave therapy machines and custom orthotics imported from Germany and Italy by 25-30%, resulting in prolonged patient pain management and higher podiatry clinic operational expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of obesity is expected to drive the growth of the plantar fasciitis market in the future. Obesity is a health concern characterized by an abnormal or excessive accumulation of fat. A body mass index (BMI) of 25 or greater is classified as overweight, while a BMI above 30 is considered obese. Individuals with a normal weight have nearly six times lower chances of developing plantar fasciitis compared to those with a BMI of 30 or higher. For example, data released in 2022 by the Centers for Disease Control and Prevention (CDC), a US government agency, shows that 22 states now report an adult obesity prevalence of 35% or higher, an increase from 19 states in 2021. Thus, the rise in obesity is driving the expansion of the plantar fasciitis market.

The growth of the plantar fasciitis treatment market is anticipated to be propelled by the rising prevalence of diabetes. Diabetes, characterized by elevated blood sugar levels, leads to complications such as foot pain and discomfort due to inflammation of the plantar fascia. Plantar fasciitis treatment in diabetes aims to alleviate these symptoms, enhance mobility, and reduce the risk of complications. The IDF Diabetes Atlas reported in 2021 that globally, 537 million people were affected by diabetes, with an estimated 643 million individuals projected to be impacted by 2030 and a significant increase to 783 million by 2045. This surge in diabetes cases is a major driver for the plantar fasciitis treatment market.

Technological advancements are emerging as a prominent trend in the plantar fasciitis treatment market. Leading companies in the market are actively developing and implementing innovative technologies to transform the treatment landscape for plantar heel pain. In December 2022, ZetrOZ Systems introduced the Sam X1, a wireless ultrasound device with FDA certification for at-home usage, offering a regenerative treatment alternative for soft tissue injuries and plantar fasciitis. This device, proven effective in treating various injuries, widens blood vessels to enhance blood flow, promoting healing without drugs or surgery.

Major companies in the plantar fasciitis treatment market are focusing on technological initiatives such as dedicated platforms for accessing global 3D foot scan data. Aetrex, a US-based foot technology company, launched the Foot.com Data Portal in September 2022, providing footwear brands with comprehensive 3D foot scan data to enhance the development of better-fitting shoes. The portal, supported by Aetrex's foot scanners, Albert 2 Pro and Albert 3DFit, offers accurate measurements and assists brands in improving the design of anatomically correct lasts for enhanced comfort and performance.

In October 2022, Patient Square Capital's acquisition of Hanger Inc. for approximately $1.25 billion is a noteworthy development in the plantar fasciitis treatment market. This acquisition is expected to support Hanger in future growth initiatives, particularly in providing innovative and high-quality care through its medical devices, including ankle-foot orthoses (AFO) used in the treatment of plantar fasciitis.

Major companies operating in the plantar fasciitis treatment market include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl's Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc.

North America was the largest region in the plantar fasciitis treatment market in 2024. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the plantar fasciitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plantar fasciitis treatment market includes revenues earned by entities by provide extracorporeal shock wave therapy (ESWT), intracorporeal pneumatic shock wave therapy (IPST), inflammation-related pain drugs, and non-operative treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plantar Fasciitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plantar fasciitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plantar fasciitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plantar fasciitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Medication Therapy; Orthotics; Shockwave Therapy; Surgery; Other Types
• 2) By Diagnosis: Medical History; Physical Examination; X-Rays; Radiography; Other Diagnosis
• 3) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Pain Relievers; Topical Treatments
• 2) By Orthotics: Custom Orthotic Inserts; Over-The-Counter Insoles; Night Splints; Heel Cups
• 3) By Shockwave Therapy: Radial Shockwave Therapy; Focused Shockwave Therapy
• 4) By Surgery: Plantar Fascia Release; Gastrocnemius Recession; Other Surgical Procedures
• 5) By Other Types: Physical Therapy; Massage Therapy; Stretching And Strengthening Exercises; Alternative Therapies
• Companies Mentioned: Bayer AG; Superfeet Worldwide LLC; Bauerfeind AG; Ottobock SE & Co. KGaA; Shapecrunch Technology Pvt. Ltd.; Sanofi SA; Eli Lilly and Company; GlaxoSmithKline plc; Pfizer Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Scholl's Wellness Co.; Hanger Inc.; Merck & Co. Inc.; Johnson & Johnson Services Inc.; Smith & Nephew plc; Arthrex Inc.; DJO Global Co.; Medline Industries Inc.; Bird & Cronin Inc.; Aetrex Worldwide Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plantar Fasciitis Treatment Market Characteristics

3. Plantar Fasciitis Treatment Market Trends And Strategies

4. Plantar Fasciitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Plantar Fasciitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plantar Fasciitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plantar Fasciitis Treatment Market Growth Rate Analysis
• 5.4. Global Plantar Fasciitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plantar Fasciitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plantar Fasciitis Treatment Total Addressable Market (TAM)

6. Plantar Fasciitis Treatment Market Segmentation

• 6.1. Global Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication Therapy
• Orthotics
• Shockwave Therapy
• Surgery
• Other Types
• 6.2. Global Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical History
• Physical Examination
• X-Rays
• Radiography
• Other Diagnosis
• 6.3. Global Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.4. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroids
• Pain Relievers
• Topical Treatments
• 6.5. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Orthotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom Orthotic Inserts
• Over-The-Counter Insoles
• Night Splints
• Heel Cups
• 6.6. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Shockwave Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radial Shockwave Therapy
• Focused Shockwave Therapy
• 6.7. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plantar Fascia Release
• Gastrocnemius Recession
• Other Surgical Procedures
• 6.8. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Massage Therapy
• Stretching And Strengthening Exercises
• Alternative Therapies

7. Plantar Fasciitis Treatment Market Regional And Country Analysis

• 7.1. Global Plantar Fasciitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plantar Fasciitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plantar Fasciitis Treatment Market

• 8.1. Asia-Pacific Plantar Fasciitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plantar Fasciitis Treatment Market

• 9.1. China Plantar Fasciitis Treatment Market Overview
• 9.2. China Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plantar Fasciitis Treatment Market

• 10.1. India Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plantar Fasciitis Treatment Market

• 11.1. Japan Plantar Fasciitis Treatment Market Overview
• 11.2. Japan Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plantar Fasciitis Treatment Market

• 12.1. Australia Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plantar Fasciitis Treatment Market

• 13.1. Indonesia Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plantar Fasciitis Treatment Market

• 14.1. South Korea Plantar Fasciitis Treatment Market Overview
• 14.2. South Korea Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plantar Fasciitis Treatment Market

• 15.1. Western Europe Plantar Fasciitis Treatment Market Overview
• 15.2. Western Europe Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plantar Fasciitis Treatment Market

• 16.1. UK Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plantar Fasciitis Treatment Market

• 17.1. Germany Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plantar Fasciitis Treatment Market

• 18.1. France Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plantar Fasciitis Treatment Market

• 19.1. Italy Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plantar Fasciitis Treatment Market

• 20.1. Spain Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plantar Fasciitis Treatment Market

• 21.1. Eastern Europe Plantar Fasciitis Treatment Market Overview
• 21.2. Eastern Europe Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plantar Fasciitis Treatment Market

• 22.1. Russia Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plantar Fasciitis Treatment Market

• 23.1. North America Plantar Fasciitis Treatment Market Overview
• 23.2. North America Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plantar Fasciitis Treatment Market

• 24.1. USA Plantar Fasciitis Treatment Market Overview
• 24.2. USA Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plantar Fasciitis Treatment Market

• 25.1. Canada Plantar Fasciitis Treatment Market Overview
• 25.2. Canada Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plantar Fasciitis Treatment Market

• 26.1. South America Plantar Fasciitis Treatment Market Overview
• 26.2. South America Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plantar Fasciitis Treatment Market

• 27.1. Brazil Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plantar Fasciitis Treatment Market

• 28.1. Middle East Plantar Fasciitis Treatment Market Overview
• 28.2. Middle East Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plantar Fasciitis Treatment Market

• 29.1. Africa Plantar Fasciitis Treatment Market Overview
• 29.2. Africa Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plantar Fasciitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Plantar Fasciitis Treatment Market Competitive Landscape
• 30.2. Plantar Fasciitis Treatment Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Superfeet Worldwide LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bauerfeind AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Ottobock SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Shapecrunch Technology Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Plantar Fasciitis Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Eli Lilly and Company
• 31.3. GlaxoSmithKline plc
• 31.4. Pfizer Inc.
• 31.5. Bristol-Myers Squibb Company
• 31.6. F. Hoffmann-La Roche Ltd.
• 31.7. Scholl's Wellness Co.
• 31.8. Hanger Inc.
• 31.9. Merck & Co. Inc.
• 31.10. Johnson & Johnson Services Inc.
• 31.11. Smith & Nephew plc
• 31.12. Arthrex Inc.
• 31.13. DJO Global Co.
• 31.14. Medline Industries Inc.
• 31.15. Bird & Cronin Inc.

32. Global Plantar Fasciitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plantar Fasciitis Treatment Market

34. Recent Developments In The Plantar Fasciitis Treatment Market

35. Plantar Fasciitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Plantar Fasciitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plantar Fasciitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plantar Fasciitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer